These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 27343418)
21. The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment. Gil RJ; Bil J; Pawłowski T; Yuldashev N; Kołakowski L; Jańczak J; Jabłoński W; Paliński P Kardiol Pol; 2016; 74(7):627-33. PubMed ID: 26779846 [TBL] [Abstract][Full Text] [Related]
22. Expansion and malapposition characteristics after bioresorbable vascular scaffold implantation. Brown AJ; McCormick LM; Braganza DM; Bennett MR; Hoole SP; West NE Catheter Cardiovasc Interv; 2014 Jul; 84(1):37-45. PubMed ID: 24403223 [TBL] [Abstract][Full Text] [Related]
23. The effect of coronary artery plaque composition, morphology and burden on Absorb bioresorbable vascular scaffold expansion and eccentricity - A detailed analysis with optical coherence tomography. Shaw E; Allahwala UK; Cockburn JA; Hansen TCE; Mazhar J; Figtree GA; Hansen PS; Bhindi R Int J Cardiol; 2015 Apr; 184():230-236. PubMed ID: 25723650 [TBL] [Abstract][Full Text] [Related]
24. Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions. Cortese B; Ielasi A; Romagnoli E; Varricchio A; Cuculo A; Loi B; Pisano F; Corrado D; Sesana M; La Vecchia L; Summaria F; Tespili M; Silva Orrego P; Tognoni G; Steffenino G Am J Cardiol; 2015 Sep; 116(5):705-10. PubMed ID: 26100584 [TBL] [Abstract][Full Text] [Related]
25. Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds--an optical coherence tomography substudy of the EVERBIO II trial. Kallinikou Z; Arroyo D; Togni M; Lehman S; Corpataux N; Cook M; Müller O; Baeriswyl G; Stauffer JC; Goy JJ; Puricel SG; Cook S Swiss Med Wkly; 2016; 146():w14274. PubMed ID: 26766027 [TBL] [Abstract][Full Text] [Related]
26. One-Year Results of Bioresorbable Vascular Scaffolds for Coronary Chronic Total Occlusions. Vaquerizo B; Barros A; Pujadas S; Bajo E; Jiménez M; Gomez-Lara J; Jacobi F; Salvatella N; Pons G; Cinca J; Serra A Am J Cardiol; 2016 Mar; 117(6):906-17. PubMed ID: 26874547 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of parameters of suboptimal scaffold deployment following angiographic guided bioresorbable vascular scaffold implantation in real world practice - an optical coherence tomography analysis. Subban V; Sengottuvelu G; Uthayakumaran K; Rajendran R; Janakiraman E; Pakshirajan B; Thenpally JG; Kalidoss L; Victor SM; Kalarickal MS; Ajit MS Int J Cardiol; 2016 Oct; 220():32-42. PubMed ID: 27372040 [TBL] [Abstract][Full Text] [Related]
28. Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study. Vaquerizo B; Barros A; Pujadas S; Bajo E; Estrada D; Miranda-Guardiola F; Rigla J; Jiménez M; Cinca J; Serra A EuroIntervention; 2015 Sep; 11(5):555-63. PubMed ID: 25499833 [TBL] [Abstract][Full Text] [Related]
29. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process. Gutiérrez-Chico JL; Gijsen F; Regar E; Wentzel J; de Bruyne B; Thuesen L; Ormiston J; McClean DR; Windecker S; Chevalier B; Dudek D; Whitbourn R; Brugaletta S; Onuma Y; Serruys PW JACC Cardiovasc Interv; 2012 Apr; 5(4):428-35. PubMed ID: 22516401 [TBL] [Abstract][Full Text] [Related]
30. The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing. Džavík V; Colombo A JACC Cardiovasc Interv; 2014 Jan; 7(1):81-8. PubMed ID: 24332424 [TBL] [Abstract][Full Text] [Related]
31. One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 Study. Widimsky P; Petr R; Tousek P; Maly M; Linkova H; Vrana J; Hajsl M; Budesinsky T; Lisa L; Kocka V Circ Cardiovasc Interv; 2015 Dec; 8(12):e002933. PubMed ID: 26628591 [TBL] [Abstract][Full Text] [Related]
32. Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry. Imori Y; D'Ascenzo F; Gori T; Münzel T; Fabrizio U; Campo G; Cerrato E; Napp LC; Iannaccone M; Ghadri JR; Kazemian E; Binder RK; Jaguszewski M; Csordas A; Capasso P; Biscaglia S; Conrotto F; Varbella F; Garbo R; Gaita F; Erne P; Lüscher TF; Moretti C; Frangieh AH; Templin C Cardiol J; 2016; 23(4):374-83. PubMed ID: 27515481 [TBL] [Abstract][Full Text] [Related]
33. Coronary artery bifurcation with chronic total occlusion: A "biodegradable" strategy for a challenging treatment with optical coherence tomography analysis. Inga G; Buccheri D; Piraino D; Carella M; Andolina G Int J Cardiol; 2016 Sep; 218():23-24. PubMed ID: 27232906 [No Abstract] [Full Text] [Related]
34. Angiographic and Midterm Outcomes of Bioresorbable Vascular Scaffold for Coronary Bifurcation Lesions. Paradies V; Vlachojannis GJ; Royaards KJ; Wassing J; van der Ent M; Smits PC Am J Cardiol; 2018 Dec; 122(12):2035-2042. PubMed ID: 30360886 [TBL] [Abstract][Full Text] [Related]
36. New insights on acute expansion and longitudinal elongation of bioresorbable vascular scaffolds in vivo and at bench test: a note of caution on reliance to compliance charts and nominal length. Attizzani GF; Ohno Y; Capodanno D; Francaviglia B; Grasso C; Sgroi C; Wang W; Fujino Y; Ganocy SJ; Longo G; Tamburino CI; Di Salvo M; La Manna A; Capranzano P; Tamburino C Catheter Cardiovasc Interv; 2015 Mar; 85(4):E99-E107. PubMed ID: 25154722 [TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update. Toušek P; Kočka V; Malý M; Kozel M; Petr R; Hajsl M; Jarkovský J; Lisa L; Buděšínský T; Widimský P EuroIntervention; 2016 May; 12(1):23-9. PubMed ID: 27173858 [TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of BVS from a prospective multicenter registry: Impact of a dedicated implantation technique on clinical outcomes. Regazzoli D; Latib A; Ezhumalai B; Tanaka A; Leone PP; Khan S; Kumar V; Rastogi V; Ancona MB; Mangieri A; Giannini F; Mitomo S; Seth A; Colombo A Int J Cardiol; 2018 Nov; 270():113-117. PubMed ID: 29983253 [TBL] [Abstract][Full Text] [Related]
39. Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery. Wu Y; Shen L; Ge L; Wang Q; Qian J; Zhang F; Yao K; Huang D; Chen Y; Ge J Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():630-7. PubMed ID: 26864162 [TBL] [Abstract][Full Text] [Related]
40. Bioresorbable vascular scaffolds for left main lesions; a novel strategy to overcome limitations. Miyazaki T; Panoulas VF; Sato K; Naganuma T; Latib A; Colombo A Int J Cardiol; 2014 Jul; 175(1):e11-3. PubMed ID: 24845788 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]